Practice
Diagnosing dementia
David C. Wang, Sandra E. Black and Katherine A. Zukotynski
CMAJ May 17, 2016 188 (8) 603; DOI: https://doi.org/10.1503/cmaj.150508
David C. Wang
Faculty of Medicine (Wang) and Department of Medicine (Black), University of Toronto; Sunnybrook Health Sciences Centre (Black), University of Toronto; Institute of Biomaterials and Biomedical Engineering (Black, Zukotynski), University of Toronto, Toronto, Ont.; Departments of Medicine and Radiology (Zukotynski), McMaster University, Hamilton, Ont.
BHSc (Honours)Sandra E. Black
Faculty of Medicine (Wang) and Department of Medicine (Black), University of Toronto; Sunnybrook Health Sciences Centre (Black), University of Toronto; Institute of Biomaterials and Biomedical Engineering (Black, Zukotynski), University of Toronto, Toronto, Ont.; Departments of Medicine and Radiology (Zukotynski), McMaster University, Hamilton, Ont.
MDKatherine A. Zukotynski
Faculty of Medicine (Wang) and Department of Medicine (Black), University of Toronto; Sunnybrook Health Sciences Centre (Black), University of Toronto; Institute of Biomaterials and Biomedical Engineering (Black, Zukotynski), University of Toronto, Toronto, Ont.; Departments of Medicine and Radiology (Zukotynski), McMaster University, Hamilton, Ont.
MDIn this issue
Article tools
Diagnosing dementia
David C. Wang, Sandra E. Black, Katherine A. Zukotynski
CMAJ May 2016, 188 (8) 603; DOI: 10.1503/cmaj.150508
Jump to section
- Article
- Dementia is a clinical diagnosis
- Anatomic imaging is the first-line imaging modality in dementia
- Nuclear medicine brain scans can be useful in atypical dementia
- Positron emission tomography may be helpful to evaluate brain metabolism or amyloid deposition
- Cerebrospinal fluid biomarkers are used for investigational purposes
- Footnotes
- References
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.